Diagnosis of CML is based on characteristic blood findings co-existent with the presence of the Philadelphia chromosome or detection of BCR-ABL1 fusion gene by polymerase chain reaction (PCR) or fluorescent in situ hybridisation (FISH) [6]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.